Cargando…

Correction: Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488833/ https://www.ncbi.nlm.nih.gov/pubmed/32929050 http://dx.doi.org/10.1136/jitc-2019-000271corr1

Ejemplares similares

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
por: Klaver, Yarne, et al.
Publicado: (2020)

Immune checkpoint inhibitor resistance in soft tissue sarcoma
por: Eulo, Vanessa, et al.
Publicado: (2022)

Correction: On the mechanism of anti-CD39 immune checkpoint therapy
Publicado: (2020)

Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas
por: Hashimoto, Kazuhiko, et al.
Publicado: (2021)

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2019)

Correction to: Pretreatment tumor sampling and prognostic factors in patients with soft-tissue sarcoma of the head and neck
por: Roos, Johan H., et al.
Publicado: (2021)

Correction to: Predicting risk of metastases and recurrence in soft-tissue sarcomas via Radiomics and Formal Methods
Publicado: (2023)

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
por: Dufresne, A., et al.
Publicado: (2020)

Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
por: Kim, Min Hwan, et al.
Publicado: (2020)

Correction: Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue
por: Murillo, Jimmy Rodriguez, et al.
Publicado: (2018)

ERRATUM: Oncological outcome and prognostic factors in the therapy of soft tissue sarcoma of the extremities
por: Ipach, Ingmar, et al.
Publicado: (2013)

Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells
por: Sabins, Nina C., et al.
Publicado: (2016)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas
por: ATSUMI, SATORU, et al.
Publicado: (2013)

Correction: Characterization of CD8+ T Cell Differentiation following SIVΔnef Vaccination by Transcription Factor Expression Profiling
Publicado: (2015)

MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma
por: Sachdeva, Mohit, et al.
Publicado: (2015)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Publicado: (2020)

Correction: Immune checkpoint inhibitor-associated celiac disease
Publicado: (2020)

Correction: T lymphocyte-targeted immune checkpoint modulation in glioma
Publicado: (2020)

Correction: Health-related quality of Life in patients with advanced soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study
Publicado: (2020)

Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy
por: Tuna, Musaffe, et al.
Publicado: (2012)

Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China
por: Yang, Zhixun, et al.
Publicado: (2019)

Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging
por: Gustafson, Claire E., et al.
Publicado: (2017)

CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma
por: Su, Yanhong, et al.
Publicado: (2021)

Correction: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
por: Akhmetzyanova, Ilseyar, et al.
Publicado: (2015)

Correction to ‘An empirical measure of nonlinear strain for soft tissue indentation’
por: MacManus, D. B., et al.
Publicado: (2018)

Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Correction: A Systematic Review of Mapping Strategies for the Sonification of Physical Quantities
Publicado: (2014)

Correction: Oscillatory brain activity reveals linguistic prints in the quantity code
por: Salillas, Elena, et al.
Publicado: (2015)

Expression of heparanase in soft tissue sarcomas of adults
por: Kazarin, Olga, et al.
Publicado: (2014)

GEFT aberrant expression in soft tissue sarcomas
por: Liu, Yang, et al.
Publicado: (2019)

Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors
Publicado: (2023)

Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
por: Kiaie, Seyed Hossein, et al.
Publicado: (2023)

Correction to: CD33 BiTE(®) molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
por: Marcinek, Anetta, et al.
Publicado: (2023)

Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
por: Barretina, Jordi, et al.
Publicado: (2010)

Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
por: Zhu, Zhenhua, et al.
Publicado: (2020)

Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31leuguhc5jhf2mu3iap6nfpgc